Latest Coagulation Stories
Data showing improved pharmacokinetic profile to be presented at World Federation of Hemophilia Congress MELBOURNE, Australia, May 11, 2014 /PRNewswire/ -- Interim Phase II/III and
LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
KING OF PRUSSIA, Pa., May 2, 2014 /PRNewswire/ -- CSL Behring today announced that the first patient has been enrolled
- Three-year commitment of up to 20 million units per year of blood clotting medicines to treat hemophilia patients in developing countries BARCELONA, Spain, April 17, 2014 /PRNewswire/
Donated coagulation factor supports WFH Global Alliance for Progress program KING OF PRUSSIA, Pa., April 17, 2014 /PRNewswire/ --
LONDON, April 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
6.9 million people have a bleeding disorder.
Right now, options are limited for preventing heart attacks.
The Approval of ALPROLIX is First Significant Advance in Hemophilia B Treatment in More Than 17 Years CAMBRIDGE, MA, March 24, 2014 /CNW/ -
Defective blood coagulation is one of the leading causes of preventable death in patients who have suffered trauma or undergone surgery.
- The parings of haberdine; also, any kind of fragments.